Daniel Weibel

Assistant Professor

Strategic program(s):

Contact

dweibel@umcutrecht.nl

Pure profile

Research groups

Real World Evidence group

Research aim

The Real-World Evidence group at the University Medical Center Utrecht has the vision that we should generate best evidence from real world data in a learning health care system.

Go to group

Recent publications

All publications

Experiences and perceptions about vaccines and reporting of adverse events following immunisation Nana Akosua Ansah, Daniel Weibel, Samuel Tamti Chatio, Samuel Tomilola Oladokun, Enyonam Duah, Patrick Ansah, Abraham Oduro, Miriam Sturkenboom
BMJ Public Health, 2025, vol. 3

Vaccine Safety Issues in Resource-Limited Countries Daniel Weibel, Miriam Sturkenboom, Robert T. Chen, Osemeke Osokogu, Chioma Ejekam, Rebecca Chandler, Jyoti Joshi, Patrick Zuber, Steven Black, Silvia Perez-Vilar, Esperanca Sevene, Sammy Khagayi, Mandyam Ravi, Bruce Fireman, Laurence Baril, Sonali Kochhar, Jane Gidudu
2025, p.211-247

Barriers and strategies to improve vaccine adverse events reporting Nana Akosua Ansah, Daniel Weibel, Samuel Tamti Chatio, Samuel Tomilola Oladokun, Enyonam Duah, Patrick Ansah, Abraham Oduro, Marieke Hollestelle, Miriam Sturkenboom
BMJ public health, 2025, vol. 3, p.1-10

COVID-19 vaccine safety studies among special populations Sima Mohammadi, Malede Mequanent Sisay, Putri Widi Saraswati, Alhadi Khogali Osman, Nicolaas P A Zuithoff, Daniel Weibel, Miriam Sturkenboom, Fariba Ahmadizar
Vaccine, 2025, vol. 61

Real-World Evidence BRIDGE Albert Cid Royo, Roel Elbers Jhj, Daniel Weibel, Vjola Hoxhaj, Zeynep Kurkcuoglu, Miriam C J Sturkenboom, Tiago A Vaz, Constanza L Andaur Navarro
Pharmacoepidemiology and Drug Safety, 2024, vol. 33

Authors' Reply to Juergen O Kirchner's Comment on "Incidence Rates of Autoimmune Diseases in European Healthcare Databases Corinne Willame, Daniel Weibel, Miriam C J M Sturkenboom
Drug Safety, 2023, vol. 46, p.813-815